CGRP antagonist approved to prevent migraine in adults with episodic and chronic migraine

Trial will evaluate whether Mavenclad can slow the rate of upper limb disability progression

Combination treatment scored EU approval earlier this year

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Researchers have identified three drugs, already approved for other uses in humans, as possible therapeutics for COVID-19, the […]

A computational method that combines clinicodemographic variables with deep learning of pre-treatment histology images could predict response to […]